| Literature DB >> 33923923 |
Francesca Danesi1,2, Carlo Mengucci1, Simona Vita1, Achim Bub3, Stephanie Seifert3, Corinne Malpuech-Brugère4, Ruddy Richard5, Caroline Orfila6, Samantha Sutulic6, Luigi Ricciardiello7, Elisa Marcato7, Francesco Capozzi1,2, Alessandra Bordoni1,2.
Abstract
Although lifestyle-based interventions are the most effective to prevent metabolic syndrome (MetS), there is no definitive agreement on which nutritional approach is the best. The aim of the present retrospective analysis was to identify a multivariate model linking energy and macronutrient intake to the clinical features of MetS. Volunteers at risk of MetS (F = 77, M = 80) were recruited in four European centres and finally eligible for analysis. For each subject, the daily energy and nutrient intake was estimated using the EPIC questionnaire and a 24-h dietary recall, and it was compared with the dietary reference values. Then we built a predictive model for a set of clinical outcomes computing shifts from recommended intake thresholds. The use of the ridge regression, which optimises prediction performances while retaining information about the role of all the nutritional variables, allowed us to assess if a clinical outcome was manly dependent on a single nutritional variable, or if its prediction was characterised by more complex interactions between the variables. The model appeared suitable for shedding light on the complexity of nutritional variables, which effects could be not evident with univariate analysis and must be considered in the framework of the reciprocal influence of the other variables.Entities:
Keywords: energy intake; feature shrinkage; macronutrient intake; metabolic syndrome; penalised models; prevention
Year: 2021 PMID: 33923923 PMCID: PMC8072695 DOI: 10.3390/nu13041377
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
General characteristics of the study population grouped by gender (medians and interquartile ranges, IQR).
| Women | Men | ||
|---|---|---|---|
| Median (IQR) † | Median (IQR) † |
| |
| Subjects (n; %) | 77; 49.0% | 80; 51.0% | – |
| Age (years) | 58 (50–66) | 54 (46–63) | 0.0631 |
| BMI (kg/m2) | 31.6 (27.5–35.5) | 29.0 (26.1–33.0) | 0.0187 |
| WC (cm) | 100.5 (93.0–111.0) | 104.5 (99.0–113.5) | 0.0489 |
| TG (mg/dL) | 160.5 (125.1–192.6) | 188.9 (153.1–239.1) | 0.0006 |
| Total cholesterol (mg/dL) | 232.6 (201.4–254.2) | 202.7 (188.6–230.1) | <0.0001 |
| HDL-C (mg/dL) | 48.2 (41.7–56.6) | 39.2 (35.2–42.6) | <0.0001 |
| LDL-C (mg/dL) | 164.5 (138.0–180.7) | 136.0 (112.2–154.8) | <0.0001 |
| Fasting glucose (mg/dL) | 96.1 (87.4–100.8) | 97.0 (89.2–102.6) | 0.3454 |
| Fasting insulin (µIU/mL) | 12.4 (7.9–18.4) | 12.9 (9.7–18.5) | 0.5382 |
| HbA1c (%) | 5.6 (5.3–5.8) | 5.3 (5.1–5.6) | 0.0022 |
| SBP (mmHg) | 130.0 (120.0–145.0) | 130.0 (125.0–141.5) | 0.2527 |
| DBP (mmHg) | 81.0 (76.0–89.0) | 85.0 (80.0–91.0) | 0.0057 |
Abbreviations: BMI: body mass index; DBP: diastolic blood pressure; HbA1c: glycated haemoglobin; HDL-C: high-density lipoprotein (HDL) cholesterol; IQR: interquartile ranges; IU: international units; LDL-C: low-density lipoprotein (LDL) cholesterol; SBP: systolic blood pressure; TG: triglycerides; WC: waist circumference. † Median (IQR) for all parameters, except subjects (n; %). ‡ p values from Student’s t-test for normally distributed variables (WC, total cholesterol, LDL-C, DBP) and Mann–Whitney U test for non-normally distributed variables (age, BMI, TG, HDL-C, fasting glucose, fasting insulin, HbA1c, SBP).
Pearson correlation coefficients of determination (R2) for the clinical outcomes according to the ridge regression. R2 > 0.4 are in bold.
| Women | Men | |
|---|---|---|
| R2 † | R2 † | |
| BMI |
|
|
| WC | 0.39 |
|
| TG |
| 0.22 |
| Total cholesterol | 0.35 | 0.25 |
| HDL-C |
| 0.34 |
| LDL-C |
| 0.22 |
| Fasting glucose | 0.33 |
|
| Fasting insulin | 0.26 |
|
| HbA1c | 0.27 |
|
| SBP | 0.36 |
|
| DBP | 0.27 | 0.40 |
† The Pearson correlation coefficient of determination (R2) of each clinical outcome is the average of the results of each validation fold.
Figure 1Spearman’s correlation heat map of adequacy of energy/macronutrient intake (Δ, delta value calculated as difference between current intake and corresponding recommended intake of each variable) and clinical parameters at enrolment (Table 1) in (a) females and (b) males. Green circle marks an example of a different pattern in correlation between variables and targets in males and females.